Molecular Targeting Technologies, Inc.

Overview

biotechnology company focused on the development of diagnostic and therapeutic molecules to address the medical needs in cancer and cardiovascular diseases. Lead product candidates include PSVue and Tc-99m Duramycin. MTTI is also building a research reagents business and manufactures and sells an ever expanding portfolio of products, primarily based upon fluorescence, to meet the needs of cutting edge academic researchers

Classification

This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.

1. Manufacturing32
2. Chemical Manufacturing325
3. Pharmaceutical and Medicine Manufacturing32541
4. In-Vitro Diagnostic Substance Manufacturing325413

Capabilities